OBJECTIVE:The aim was to compare transanal endoscopic microsurgery (TEM) and laparoscopic resection (LR) in terms of short-term and oncologic outcomes in patients with a preoperatively diagnosed T2N0 extraperitoneal rectal cancer. METHODS:We conducted a retrospective analysis of a prospective database. All patients with a preoperatively staged T2N0 extraperitoneal rectal adenocarcinoma were considered for LR. Patients refusing LR or medically unfit for LR were considered for TEM, which was associated with neoadjuvant RT in the last cases. Only patients with a minimum follow-up of 36 months were included. RESULTS:Seventy-eight patients were included. TEM was indicated or preferred in 43 patients; of these, 11 underwent neoadjuvant RT. Morbidity was significantly lower after TEM (p < 0.001). The median follow-up was 70 (36-140) months. A higher local recurrence rate was noted after TEM (26 %), compared to neoadjuvant RT + TEM (0 %) and LR (9 %) (p = 0.070). Overall, 5-year survival rate was 76 % after TEM, 77.8 % after RT + TEM, and 96 % after LR, respectively (p = 0.134). CONCLUSIONS:While TEM alone may only be considered a palliative treatment, it might allow similar oncologic results to abdominal resection in responders to neoadjuvant RT. Large prospective randomized trials are awaited to confirm these findings.

Transanal endoscopic microsurgery vs. laparoscopic total mesorectal excision for T2N0 rectal cancer

ALLAIX, Marco Ettore;AREZZO, Alberto;MORINO, Mario
2012-01-01

Abstract

OBJECTIVE:The aim was to compare transanal endoscopic microsurgery (TEM) and laparoscopic resection (LR) in terms of short-term and oncologic outcomes in patients with a preoperatively diagnosed T2N0 extraperitoneal rectal cancer. METHODS:We conducted a retrospective analysis of a prospective database. All patients with a preoperatively staged T2N0 extraperitoneal rectal adenocarcinoma were considered for LR. Patients refusing LR or medically unfit for LR were considered for TEM, which was associated with neoadjuvant RT in the last cases. Only patients with a minimum follow-up of 36 months were included. RESULTS:Seventy-eight patients were included. TEM was indicated or preferred in 43 patients; of these, 11 underwent neoadjuvant RT. Morbidity was significantly lower after TEM (p < 0.001). The median follow-up was 70 (36-140) months. A higher local recurrence rate was noted after TEM (26 %), compared to neoadjuvant RT + TEM (0 %) and LR (9 %) (p = 0.070). Overall, 5-year survival rate was 76 % after TEM, 77.8 % after RT + TEM, and 96 % after LR, respectively (p = 0.134). CONCLUSIONS:While TEM alone may only be considered a palliative treatment, it might allow similar oncologic results to abdominal resection in responders to neoadjuvant RT. Large prospective randomized trials are awaited to confirm these findings.
2012
16
12
2280
2287
Allaix M.E.; Arezzo A.; Giraudo G.; Morino M.
File in questo prodotto:
File Dimensione Formato  
TRANSANAL art%3A10.1007%2Fs11605-012-2046-8.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 235.06 kB
Formato Adobe PDF
235.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Transanal Endoscopic Microsurgery vsOA_4aperto.pdf

Open Access dal 01/02/2014

Descrizione: POST PRINT (12 MESI EMBARGO)
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 316.56 kB
Formato Adobe PDF
316.56 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/120803
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 36
social impact